Literature DB >> 15156399

Seroprevalence of HSV-1 and HSV-2 in Barbados.

P N Levett1.   

Abstract

Type-specific enzyme-linked immunosorbent assays, based upon recombinant glycoprotein G (gG), were used to detect antibodies to HSV-1 and HSV-2, in a small Caribbean island population. A blinded serosurvey was performed on samples from 184 blood donors, 122 pregnant women, and 120 HIV-positive patients. The seroprevalence of HSV-1 and HSV-2 was 81% and 34%, respectively, in blood donors, 84% and 40% in the antenatal population and 89% and 77% in the HIV-positive group. As expected the majority of adults were seropositive against HSV-1. However, the HSV-2 seroprevalence was significantly higher in HIV-infected adults than in the other groups. These findings support the need for prospective epidemiological studies in this population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15156399     DOI: 10.1007/s00430-004-0222-5

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  15 in total

1.  Sexual and demographic risk factors for herpes simplex type 1 and 2 in women attending an antenatal clinic.

Authors:  R L Tideman; J Taylor; C Marks; C Seifert; G Berry; B Trudinger; A Cunningham; A Mindel
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

2.  A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.

Authors:  A G Langenberg; L Corey; R L Ashley; W P Leong; S E Straus
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

3.  Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany.

Authors:  H F Rabenau; S Buxbaum; W Preiser; B Weber; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2002-03       Impact factor: 3.402

4.  A sero-epidemiological study of herpes virus type 1 and 2 infection in Israel.

Authors:  Meir Isacsohn; Zahava Smetana; Zichria Zakai Rones; David Raveh; Yoram Diamant; Arnon Samueloff; Michel Shaya; Ella Mendelson; Paul Slater; Bernard Rudenski; Elchanan Bar On; Abraham Morag
Journal:  J Clin Virol       Date:  2002-02       Impact factor: 3.168

5.  Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention.

Authors:  F X Mbopi-Kéou; G Grésenguet; P Mayaud; H A Weiss; R Gopal; M Matta; J L Paul; D W Brown; R J Hayes; D C Mabey; L Bélec
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

6.  Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Authors:  A Wald; J Zeh; S Selke; T Warren; A J Ryncarz; R Ashley; J N Krieger; L Corey
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

7.  Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994.

Authors:  Fujie Xu; Julia A Schillinger; Maya R Sternberg; Robert E Johnson; Francis K Lee; Andre J Nahmias; Lauri E Markowitz
Journal:  J Infect Dis       Date:  2002-03-22       Impact factor: 5.226

8.  Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents.

Authors:  Charles T Leach; Rhoda L Ashley; Jacques Baillargeon; Hal B Jenson
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 9.  Genital herpes: review of the epidemic and potential use of type-specific serology.

Authors:  R L Ashley; A Wald
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

10.  Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada.

Authors:  Michelle Howard; John W Sellors; Dan Jang; Noah J Robinson; Margaret Fearon; Janusz Kaczorowski; Max Chernesky
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more
  6 in total

1.  High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.

Authors:  Craig S Miller; Joseph R Berger; Yunanan Mootoor; Sergei A Avdiushko; Hua Zhu; Richard J Kryscio
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  Seroprevalence and Influence of Torch Infections in High Risk Pregnant Women: A Large Study from South India.

Authors:  K Rebekah Prasoona; B Srinadh; T Sunitha; M Sujatha; M L N Deepika; B Vijaya Lakshmi; Aruna Ramaiah; A Jyothy
Journal:  J Obstet Gynaecol India       Date:  2014-10-29

3.  Herpes simplex virus type 1 epidemiology in Latin America and the Caribbean: Systematic review and meta-analytics.

Authors:  Layan Sukik; Maryam Alyafei; Manale Harfouche; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2019-04-22       Impact factor: 3.240

4.  Evaluation of an Automated Chemiluminescent Immunoassay in Typing Detection of IgG Antibodies Against Herpes Simplex Virus.

Authors:  Zhiyan Li; Rong Yan; Cunling Yan; Ping Liu; Zhenru Feng
Journal:  J Clin Lab Anal       Date:  2015-12-14       Impact factor: 2.352

5.  Seroepidemiology of herpes simplex virus type 1 and 2 in northern iran.

Authors:  S Rezaei-Chaparpordi; M Assmar; N Amirmozafari; L Modiri; A Massiha; S Shokri-Fashtali; Z Gholizadeh; S Akbari
Journal:  Iran J Public Health       Date:  2012-08-31       Impact factor: 1.429

Review 6.  Disturbed Yin-Yang balance: stress increases the susceptibility to primary and recurrent infections of herpes simplex virus type 1.

Authors:  Chang Yan; Zhuo Luo; Wen Li; Xue Li; Robert Dallmann; Hiroshi Kurihara; Yi-Fang Li; Rong-Rong He
Journal:  Acta Pharm Sin B       Date:  2019-06-22       Impact factor: 11.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.